Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply

Lancet. 2013 Aug 3;382(9890):395. doi: 10.1016/S0140-6736(13)61670-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / therapy*
  • Female
  • Humans
  • Male

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents